Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Inhaled Pre-prandial Human Insulin Versus Subcutaneous Injected Insulin Aspart in Subjects With Diabetes and Chronic Obstructive Pulmonary Disease: A 52-week Open Label, Multicentre, Randomized, Parallel Trial to Investigate Long-term Safety

NCT00472953 is registered in ClinicalTrials.gov with Novo Nordisk A/S as lead sponsor.

NCT NCT00472953
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00472953 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Inhaled Pre-prandial Human Insulin Versus Subcutaneous Injected Insulin Aspart in Subjects With Diabetes and Chronic Obstructive Pulmonary Disease: A 52-week Open Label, Multicentre, Randomized, Parallel Trial to Investigate Long-term Safety
Lead sponsor
Novo Nordisk A/S
Phase
Phase 3
Overall status
Terminated
Start date
May 15, 2007
Completion date
March 5, 2008
Enrollment
38 (actual)
Sites
27

Conditions

As the registry lists them; a condition with its own page is linked.

chronic obstructive pulmonary disease, diabetes, diabetes mellitus, type 1, diabetes mellitus, type 2